Mavacoxib

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Mavacoxib
Mavacoxib.svg
Clinical data
Trade names Trocoxil
AHFS/Drugs.com International Drug Names
Legal status
?
Identifiers
CAS number 170569-88-7
ATCvet code QM01AH92
PubChem CID 9843089
ChemSpider 8018804
UNII YFT7X7SR77
ChEBI CHEBI:76207
Chemical data
Formula C16H11F4N3O2S 
Mol. mass 385 g/mol

Mavacoxib (trade name Trocoxil) is a veterinary drug used to treat pain and inflammation in dogs with degenerative joint disease.[1] It acts as a COX-2 inhibitor.[2]

References[edit]

  1. ^ European Public Assessment Report (EPAR): Trocoxil, European Medicines Agency
  2. ^ Cox, S. R.; Lesman, S. P.; Boucher, J. F.; Krautmann, M. J.; Hummel, B. D.; Savides, M.; Marsh, S.; Fielder, A.; Stegemann, M. R. (2010). "The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogs". Journal of Veterinary Pharmacology and Therapeutics 33 (5): 461–70. doi:10.1111/j.1365-2885.2010.01165.x. PMID 20840390.